KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.

Yazar
BERGSLAND, E
WEISER, MR
BERGER, MF
PATIL, S
GARCIA-AGUILAR, J
Keskin, Metin
KUK, D
CHOW, OS
SMITH, JJ
CAMACHO, N
PELOSSOF, R
CHEN, CT
CHEN, Z
AVILA, K
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/29358
https://doi.org/10.1245/s10434-016-5205-4
Koleksiyonlar